Clinical Trial Update: A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating olaratumab in combination with doxorubicin in advanced soft tissue sarcoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Olaratumab (olaratumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sarcoma, Soft Tissue | Phase 1 | Status: COMPLETED | Results posted: 2019-11-21